FDA Moves Up Device ID Deadline For Implantable Devices

Law360, New York (November 19, 2012, 6:29 PM EST) -- Manufacturers of life-saving medical devices would have less time to comply with the U.S. Food and Drug Administration's proposed unique device identifier rule — and, notably, less time to comply with the rule's controversial direct marking requirement for implantable devices — under an amendment released Monday.

The unique device identifier rule, when final, will require device makers to label each device with the make and model, as well as more specific information, such as expiration date or serial number. Certain devices, including those that are implanted,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.